Patent · US Active

Intrathecal hydromorphone solutions having improved stability

US10905685B2 · kind B2 · utility

0Cited by

7References

14Claims

0Family size

Assignee

PIRAMAL CRITICAL CARE, INC. · US

Inventors

John J. Foster · Windom, US
Thomas R. Prentice · Lake Elmo, US

Key dates

Filing date	Sep 6, 2013
Grant date	Feb 2, 2021
Priority date	—
Expiry date	Sep 6, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates generally to a pharmaceutical solution comprising hydromorphone or a pharmaceutically acceptable salt thereof that is substantially free of buffer and optionally one or more other additives. The pharmaceutically acceptable salt may be hydromorphone hydrochloride. Also disclosed are methods for the manufacture and use of the solution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.